One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-122336
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 12 |
Affiliation: Barts Health NHS Trust, Royal London Hospital, Imperial College London, Center for Cancer and Blood Disorders, Charles University, Massachusetts General Hospital, Principia Biopharma (United States), University Hospital St. Marina, University Hospital Brno, NewYork–Presbyterian Hospital, University Hospital Dr. Georgi StranskiPhase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
